title: Recurrent clozapine and lorazepam withdrawal psychosis with catatonia.
authors.forename: Bob Z
authors.initials: BZ
authors.lastname: Wang
authors.forename: Arun
authors.initials: A
authors.lastname: Gupta
authors.forename: Tarun
authors.initials: T
authors.lastname: Bastiampillai
authors.forename: Fariza
authors.initials: F
authors.lastname: Sani
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D002389:Catatonia / Q000139:chemically induced*; D003024:Clozapine / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D019468:Disease Management; D005260:Female; D018757:GABA Modulators / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D008140:Lorazepam / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D012074:Remission Induction; D012559:Schizophrenia / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000628:therapy*; D016896:Treatment Outcome; D028761:Withholding Treatment
chemical_list: D014150:Antipsychotic Agents; D018757:GABA Modulators; D003024:Clozapine; D008140:Lorazepam